PATENT CLAIM ANALYSIS

Application Number: 16326272
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "653000"]

Abstract:
Provided are methods of and compositions for treating or preventing lymphedema by administering a sphingosine 1-phoshate receptor modulator.

Claim (Index 14):
The method of  claim 1 , wherein the subject has undergone or is undergoing treatment for cancer.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15549156', '15554931', '13136372', '15389509', '15114572']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7757931491354746
- 35 USC 102 Novelty (BERT): 0.5607665676102545
- Combined Prediction Score: 0.7542904909829526
- Mean Citation Score: 304.6740000000001
- Max Citation Score: 461.55603
- Similarity Product: 319.38674581337386

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test